3 Defensive Dividend Stocks For Investors Rethinking AI Driven US Markets

After a powerful run in the S&P 500 and Nasdaq that has leaned heavily on a handful of AI driven giants, many investors are wondering what happens if the story changes and expensive growth gives way to old fashioned cash flow. That question matters right now because stretched valuations and bubble risk in some AI related stocks make boring dividends feel a lot less boring. This article walks through three dividend paying value stocks from our Defensive Dividend Paying Value Stocks screener that appear directly exposed to today’s market mood and explains how the same news catalysts that have fuelled the rally could either align with the goals of patient income seekers or challenge their resolve.

The three stocks covered below are just a sample from this idea. The full screen surfaced 38 more companies with equally detailed income and valuation stories that are not unpacked in this article.

If you want to identify steady cash generators for your watchlist, go straight to the Defensive Dividend-Paying Value Stocks screener to filter and analyze the highest conviction candidates for this theme.

Cardinal Health fits this defensive dividend theme as a large US healthcare distributor whose core work is keeping medicines and medical supplies moving for hospitals, pharmacies and at home care, a role that often matters more when markets are fixated on AI stories.

Cardinal Health generates most of its revenue from Pharmaceutical and Specialty Solutions at about US$234.8b, with Global Medical Products and Distribution contributing roughly US$12.7b and other activities around US$6.8b. The company carries a market value near US$51.0b.

“The expansion of specialty pharma distribution, multi specialty MSO platforms in areas like oncology, urology and gastroenterology, and a rapidly scaling Biopharma Solutions business that is ahead of its prior growth plan points to a larger mix of higher value services that can influence segment profit and overall earnings.”

What really matters for dividend focused investors is how one unresolved pressure on Cardinal Health’s cost base ultimately shapes those future margins.

That cost squeeze is the real hinge for the story, so read the full narrative for Cardinal Health to see how Cardinal Health’s earnings power could be quietly decoupling from headline risk.

Brookfield Infrastructure Corporation gives this defensive dividend screen exposure to regulated style utility assets. All its US$3.7b of revenue is tied to gas utilities infrastructure such as pipelines and connections, and it has a market value around US$4.3b that keeps it within the larger end of the income universe.

Brookfield Infrastructure appeals to income focused investors who want essential services exposure in a market skewed toward expensive AI growth, with all revenue tied to regulated style gas utility assets and a long record of regular dividends. However, the appeal of that income stream hinges on how one funding pressure plays out.

That funding wildcard is the pivot point, so review the Brookfield Infrastructure financial health report to see how Brookfield Infrastructure’s balance sheet could shape that income stream.

Cigna Group brings a large cap health insurer and services provider into this defensive dividend theme, with most revenue coming from Evernorth Health Services at about US$243.4b and Cigna Healthcare at roughly US$45.4b, plus smaller other activities, and a market value near US$71.9b.

For investors leaning toward essential services and dependable cash flows over high priced AI stories, Cigna Group offers a mix of health insurance and pharmacy services that sits squarely in the screener’s comfort zone while also tapping into a shifting earnings engine.

“Cigna Group is capitalizing on the growing demand for specialty pharmacy and care services, with recent 22% pretax earnings growth in Specialty & Care Services and a larger contribution from this segment, which points to further scaling potential that could support revenue growth and higher consolidated earnings.”

The longer term income story hinges on how one pressure inside its pharmacy benefits model ultimately feeds through to margins and cash returns.

If that pressure is what you are weighing, read the full narrative for Cigna Group to see whether Cigna Group’s earnings engine is quietly accelerating or masking deeper risks.

Seeking Alternatives Before The Crowd?

Fresh opportunities do not stay quiet for long. Screens are shifting, momentum is building, and under the radar for now ideas risk getting caught flying away. Get in early.

• Spot cash rich businesses before momentum headlines catch up by running the list of solid balance sheet and fundamentals (24 results) and focus your attention on companies with the strength to fund their own futures.
• Hunt for income ideas built around staying power using the 8 dividend fortresses and zero in on cash generating payers that aim to keep distributions coming.
• Track the infrastructure behind AI rather than only the front page tickers through the 85 AI infrastructure stocks and follow where real backbone spending goes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com